CURRICULUM VITAE Gerald Louis Andriole, Jr., M.D. Address ...

Funding Agency:
Alza Corporation
Period: 1996- 1999
Grant Title:
Feasibility, Functionality and Dose Ranging Study of DUROS Leuprolide
Implantable Therapeutic System on Patients with Advanced Prostate Cancer
Funding Agency:
Alza Corporation
Period: 1997-1999
Grant Title:
Safety and Efficacy Study of DUROS Leuprolide Implantable Therapeutic
System in Patients with Prostate Cancer
Funding Agency:
Glaxo-Wellcome
Period: 1997-1998
Grant Title:
Neoadjuvant Therapy with G1198745 in Men Undergoing
Radical Prostatectomy
Funding Agency:
DUSA Pharmaceuticals
Period: 1997-2000
Grant Title:
A Phase I/II Open-Label Pilot Study Comparing Bladder Cancer Detection Using
Transurethral Biopsies Guided by White Light and by Levulan (5-
Aminolevulinic Acid HCl, ALA) Induced Fluorescence
Funding Agency:
Alza Corporation
Period: 1999-2001
Grant Title:
Extended Safety and Efficacy Study of DUROS Leuprolide Implant in
Patients with Prostate Cancer
Funding Agency:
TherMatrx, Inc.
Period: 1998-2001
Grant Title:
Evaluation of Transurethral Microwave Thermotherapy in the Treatment of BPH
Funding Agency:
Bayer Corporation
Period: 2000-2001
Grant Title:
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Fixed-Dose,
Parallel Group, 6-Month Comparison Study To Investigate The Efficacy And
Safety Of the Phosphodiesterase Type V Inhibitor BAY 38-9456 In Males With
Erectile Dysfunction
Funding Agency:
Cell Pathways
Period: 1999-2002
Grant Title:
Neo-Adjuvant Exisulind Prior to Radical Prostatectomy
Funding Agency:
Glaxo-Wellcome
Period: 1997-2002
Grant Title:
A Randomized, Double-Blind, Placebo-Controlled, Two-Year Parallel Group
Study of the Efficacy and Safety of GI198745 0.5mg In the Treatment and
Prevention of Progression of Benign Prostatic Hyperplasia, Followed By a Two-
Year Open Label Treatment Phase
Funding Agency:
Bayer Corporation
Period: 2000-2002
Grant Title:
A Single Arm, Open-Label Phase IV Study of Viadur (leuprolide acetate
8